IBT
International Biotechnology Trust Portfolio holdings
AUM
$297M
This Quarter Return
-9.61%
1 Year Return
+17.25%
3 Year Return
+11.14%
5 Year Return
+79.35%
10 Year Return
–
AUM
$216M
AUM Growth
+$216M
(-20%)
Cap. Flow
-$18.3M
Cap. Flow
% of AUM
-8.46%
Top 10 Holdings %
Top 10 Hldgs %
56.68%
Holding
66
New
2
Increased
13
Reduced
15
Closed
8
Top Buys
| 1 |
Regeneron Pharmaceuticals
REGN
|
$4.58M |
| 2 |
CELG
Celgene Corp
CELG
|
$2.83M |
| 3 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
$2.45M |
| 4 |
AMRN
Amarin Corp
AMRN
|
$1.85M |
| 5 |
Sangamo Therapeutics
SGMO
|
$1.81M |
Top Sells
| 1 |
Halozyme
HALO
|
$6.56M |
| 2 |
Exelixis
EXEL
|
$6.01M |
| 3 |
GTHX
G1 Therapeutics, Inc. Common Stock
GTHX
|
$3.07M |
| 4 |
Biogen
BIIB
|
$2.56M |
| 5 |
Iovance Biotherapeutics
IOVA
|
$2.54M |
Sector Composition
| 1 | Healthcare | 99.71% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Gilead Sciences
GILD
$140B
| $20M | 9.26% | 316,284 | – | – |
|
|
CELG
2
DELISTED
Celgene Corp
CELG
| $17M | 7.85% | 171,022 +28,500 | +20% | +$2.83M |
|
3
Vertex Pharmaceuticals
VRTX
$100B
| $14.2M | 6.58% | 84,022 -1,000 | -1% | -$169K |
|
4
Neurocrine Biosciences
NBIX
$13.8B
| $13.3M | 6.13% | 147,300 -9,500 | -6% | -$856K |
|
5
Amgen
AMGN
$155B
| $12.8M | 5.9% | 66,000 | – | – |
|
|
6
Regeneron Pharmaceuticals
REGN
$61.5B
| $11.1M | 5.11% | 39,830 +16,500 | +71% | +$4.58M |
|
|
ALXN
7
DELISTED
Alexion Pharmaceuticals Inc
ALXN
| $10M | 4.62% | 102,141 +3,500 | +4% | +$343K |
|
|
STML
8
DELISTED
Stemline Therapeutics, Inc.
STML
| $8.7M | 4.02% | 835,245 +91,000 | +12% | +$947K |
|
9
PTC Therapeutics
PTCT
$3.92B
| $7.98M | 3.69% | 236,000 -23,000 | -9% | -$778K |
|
10
Illumina
ILMN
$15.8B
| $7.64M | 3.53% | 25,100 | – | – |
|
|
11
Biogen
BIIB
$19.4B
| $7.38M | 3.41% | 31,700 -11,000 | -26% | -$2.56M |
|
12
Incyte
INCY
$16.5B
| $7.16M | 3.31% | 96,500 +17,500 | +22% | +$1.3M |
|
13
Insmed
INSM
$28.8B
| $6.29M | 2.91% | 356,600 | – | – |
|
|
HZNP
14
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
| $5.94M | 2.74% | 218,000 +90,000 | +70% | +$2.45M |
|
15
BioMarin Pharmaceuticals
BMRN
$11.2B
| $5.88M | 2.72% | 87,284 +23,000 | +36% | +$1.55M |
|
|
SGEN
16
DELISTED
Seagen Inc. Common Stock
SGEN
| $5.67M | 2.62% | 66,400 +5,500 | +9% | +$469K |
|
|
AMRN
17
Amarin Corp
AMRN
$311M
| $3.93M | 1.81% | 259,000 +122,000 | +89% | +$1.85M |
|
|
18
Sangamo Therapeutics
SGMO
$157M
| $3.17M | 1.46% | 350,000 +200,000 | +133% | +$1.81M |
|
19
Ionis Pharmaceuticals
IONS
$6.79B
| $2.77M | 1.28% | 46,181 -36,600 | -44% | -$2.19M |
|
20
Alnylam Pharmaceuticals
ALNY
$58.5B
| $2.72M | 1.25% | 33,800 | – | – |
|
21
Acadia Pharmaceuticals
ACAD
$4.38B
| $2.45M | 1.13% | 68,000 +15,000 | +28% | +$540K |
|
|
GWPH
22
DELISTED
GW Pharmaceuticals Plc American Depositary Shares
GWPH
| $2.28M | 1.05% | 19,800 +8,800 | +80% | +$1.01M |
|
|
SAGE
23
DELISTED
Sage Therapeutics
SAGE
| $2.25M | 1.04% | 16,000 -17,996 | -53% | -$2.53M |
|
|
ABMD
24
DELISTED
Abiomed Inc
ABMD
| $2.08M | 0.96% | 11,700 | – | – |
|
25
KalVista Pharmaceuticals
KALV
$678M
| $2.06M | 0.95% | 177,433 -10,166 | -5% | -$118K |
|